Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression. | Front Cell Dev Biol | 2023 | 37025182 | PubTator, text mining | PubMed |
| Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation. | Proc Natl Acad Sci U S A | 2023 | 37014858 | PubTator, text mining | PubMed |
| Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response. | Front Cell Infect Microbiol | 2023 | 37009515 | PubTator, text mining | PubMed |
| Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond. | Front Immunol | 2023 | 37006306 | PubTator, text mining | PubMed |
| Outcomes of two different unbalanced segregations from a maternal t(4;10)(q33;p15.1) translocation. | BMC Med Genomics | 2023 | 36991446 | PubTator, text mining | PubMed |
Differential Transcriptome Responses in Human THP-1 Macrophages Following Exposure to T98G and LN-18 Human Glioblastoma Secretions: A Simplified Bioinformatics Approach to Understanding Patient-Glioma-Specific Effects on Tumor-Associated Macrophages. | Int J Mol Sci | 2023 | 36982186 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| Mechanistic Insight and Clinical Implications of Ischemia/Reperfusion Injury Post Liver Transplantation. | Cell Mol Gastroenterol Hepatol | 2023 | 36940849 | PubTator, text mining | PubMed |
| Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1. | Mol Ther Oncolytics | 2023 | 36938544 | PubTator, text mining | PubMed |
| The application of Interleukin-2 family cytokines in tumor immunotherapy research. | Front Immunol | 2023 | 36936961 | PubTator, text mining | PubMed |
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments. | J Crohns Colitis | 2023 | 36934327 | PubTator, text mining | PubMed |
| Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells. | Nat Immunol | 2023 | 36928414 | PubTator, text mining | PubMed |
| HSV: The scout and assault for digestive system tumors. | Front Mol Biosci | 2023 | 36926680 | PubTator, text mining | PubMed |
| Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys. | Nat Commun | 2023 | 36906645 | PubTator, text mining | PubMed |
| New, Low-Molecular Weight Chemical Compounds Inhibiting Biological Activity of Interleukin 15. | Molecules | 2023 | 36903533 | PubTator, text mining | PubMed |
| How to Best Protect Kidneys for Transplantation-Mechanistic Target. | J Clin Med | 2023 | 36902572 | PubTator, text mining | PubMed |
| Proteomic basis of mortality resilience mediated by FOXO3 longevity genotype. | Geroscience | 2023 | 36881352 | PubTator, text mining | PubMed |
| Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. | Kidney Blood Press Res | 2023 | 36854280 | PubTator, text mining | PubMed |
| Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection. | Viruses | 2023 | 36851579 | PubTator, text mining | PubMed |
| Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer. | Cancers (Basel) | 2023 | 36831406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=17